Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ether doai
Patent
1989-11-30
1991-08-13
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ether doai
A61K 31075
Patent
active
050397095
ABSTRACT:
The use of anipamil and its salts with physiologically tolerated acids for the treatment of chronic renal failure is described.
REFERENCES:
patent: 4593042 (1985-10-01), Liang
patent: 4798811 (1988-01-01), Lehmann et al.
Chan Laurence
Kretzschmar Rolf
Lehmann Hans D.
Schrier Robert W.
BASF - Aktiengesellschaft
Waddell Frederick E.
Wilson Terry
LandOfFree
Anipamil for the treatment of chronic renal failure does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anipamil for the treatment of chronic renal failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anipamil for the treatment of chronic renal failure will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1527695